Inventor · Piscataway, NJ, US

Purakkattle Biju

26Patents
6h-index
174Co-inventors
68Inventor score

Filing activity: Jul 30, 2003 → Aug 24, 2017

Most-cited inventions

PatentTitleAreaCited byStatus
US7132445B2 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands Chemistry; Metallurgy 36 Expired
US7638531B2 Phenoxypiperidines and analogs thereof useful as histamine H3 antagonists Chemistry; Metallurgy 18 Active
US8524697B2 C20-C21 substituted glucocorticoid receptor agonists Human Necessities 17 Active
US7947720B2 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands Chemistry; Metallurgy 9 Active
US7964646B2 3,4-DI-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands Chemistry; Metallurgy 9 Active
US7718678B2 Di-substituted oxadiazoles as CXC-chemokine receptor ligands Chemistry; Metallurgy 7 Active
US9834563B2 Antidiabetic substituted heteroaryl compounds Chemistry; Metallurgy 4 Active
US8592383B2 Cycloalkyl-fused tetrahydroquinolines as CRTH2 receptor modulators Chemistry; Metallurgy 4 Active
US9932311B2 Antidiabetic tricyclic compounds Chemistry; Metallurgy 4 Active
US8927559B2 Quinazolinone-type compounds as CRTH2 antagonists Chemistry; Metallurgy 4 Active
US7671212B2 Isothiazole dioxides as CXC- and CC-chemokine receptor ligands Chemistry; Metallurgy 3 Active
US9527875B2 Antidiabetic tricyclic compounds Chemistry; Metallurgy 3 Active
US7960433B2 Treatment of chemokine mediated diseases Human Necessities 3 Active
US10138212B2 Aminoquinazoline compounds as A2A antagonist Chemistry; Metallurgy 2 Active
US9469615B2 Quinoxalines and AZA-quinoxalines as CRTH2 receptor modulators Chemistry; Metallurgy 1 Active
US7691856B2 Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC-chemokine receptor ligands Chemistry; Metallurgy 1 Active
US10519115B2 Antidiabetic tricyclic compounds Chemistry; Metallurgy 0 Active
US10000454B2 Antidiabetic tricyclic compounds Chemistry; Metallurgy 0 Active
US10988487B2 Substituted n′-hydroxycarbamimidoyl-1,2,5-oxadiazole compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors Chemistry; Metallurgy 0 Active
US7786149B2 Thiadiazoles as CXC- and CC- chemokine receptor ligands Chemistry; Metallurgy 0 Active
US10399972B2 Tricyclic compounds as inhibitors of mutant IDH enzymes Chemistry; Metallurgy 0 Active
US7897606B2 5,6-di-substituted oxadiazolopyrazines and thiadiazolopyrazines as CXC-chemokine receptor ligands Chemistry; Metallurgy 0 Active
US10538497B2 Compounds as indoleamine 2,3-dioxygenase inhibitors Chemistry; Metallurgy 0 Active
US7985748B2 ALPHA2C adrenoreceptor agonists Chemistry; Metallurgy 0 Active
US7338968B2 Thiadiazoles AS CXC- and CC- chemokine receptor ligands Chemistry; Metallurgy 0 Expired

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.